These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25109333)

  • 1. Progastrin a new pro-angiogenic factor in colorectal cancer.
    Najib S; Kowalski-Chauvel A; Do C; Roche S; Cohen-Jonathan-Moyal E; Seva C
    Oncogene; 2015 Jun; 34(24):3120-30. PubMed ID: 25109333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated silencing of aquaporin (AQP)-5 hinders angiogenesis of colorectal tumor by suppressing the production of vascular endothelial growth factor.
    Wang W; Li Q; Yang T; Li D; Ding F; Sun H; Bai G
    Neoplasma; 2018; 65(1):55-65. PubMed ID: 29322789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.
    Zhou Q; Zhu Y; Wei X; Zhou J; Chang L; Sui H; Han Y; Piao D; Sha R; Bai Y
    Cell Death Dis; 2016 Oct; 7(10):e2413. PubMed ID: 27735951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer.
    Ren P; Sun X; Zhang C; Wang L; Xing B; Du X
    Biochem Biophys Res Commun; 2019 May; 512(4):871-876. PubMed ID: 30929921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer.
    Wu HX; Cheng X; Jing XQ; Ji XP; Chen XZ; Zhang YQ; He YG; Liu K; Ye F; Sun HX; Gao HJ; Song ZJ; Wu H; Zhang XJ; Zhang T; Zhao R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2769-2784. PubMed ID: 29751081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Liang H; Zhong Y; Zhou S; Peng L
    Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
    Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
    EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.
    Zaytseva YY; Elliott VA; Rychahou P; Mustain WC; Kim JT; Valentino J; Gao T; O'Connor KL; Neltner JM; Lee EY; Weiss HL; Evers BM
    Carcinogenesis; 2014 Jun; 35(6):1341-51. PubMed ID: 24510238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
    Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
    Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer.
    Yorozu A; Yamamoto E; Niinuma T; Tsuyada A; Maruyama R; Kitajima H; Numata Y; Kai M; Sudo G; Kubo T; Nishidate T; Okita K; Takemasa I; Nakase H; Sugai T; Takano K; Suzuki H
    Cancer Sci; 2020 May; 111(5):1631-1644. PubMed ID: 32086986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis.
    Jin G; Sakitani K; Wang H; Jin Y; Dubeykovskiy A; Worthley DL; Tailor Y; Wang TC
    Oncotarget; 2017 Jun; 8(25):40606-40619. PubMed ID: 28380450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum angiogenic activity in colorectal cancer patients.
    Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
    J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells.
    Bruns H; Kazanavicius D; Schultze D; Saeedi MA; Yamanaka K; Strupas K; Schemmer P
    Amino Acids; 2016 Nov; 48(11):2549-2558. PubMed ID: 27351202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.